Get notified when ONCY files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsOncolytics announces translational data on pelareorep to be presented at ASCO meeting
Filed May 22, 2026 · Period ending May 22, 2026 · ~1 min read
Key Changes
-
medium
Company will present translational data from GOBLET and AWARE-1 studies at the American Society of Clinical Oncology Annual Meeting, describing pelareorep's mechanism of action and effects on immune system activation.
Item 8.01 verify on EDGAR → -
medium
Data focuses on how pelareorep activates both innate and adaptive immune responses, providing scientific insight into the drug's biological activity in clinical trials.
Press Release verify on EDGAR →
This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (ADMT 10-K) is open in full — no account needed.
Partner
Trade ONCY commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · May 24, 2026 · How we verify